Daewon Pharmaceutical Co. Ltd. (003220) — Long-term Investment Intensity
Daewon Pharmaceutical Co. Ltd. (003220) has a Long-term Investment Intensity of 4.4% as of December 2019. Long-term investments of ₩14.52 Billion represent 4.4% of total assets of ₩327.53 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 003220 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Daewon Pharmaceutical Co. Ltd. Long-term Investment Intensity (2013–2019)
This chart shows how Daewon Pharmaceutical Co. Ltd.'s Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 4.4%, reflecting long-term investments of ₩14.52 Billion against total assets of ₩327.53 Billion KRW. See defensive interval ratio of Daewon Pharmaceutical Co. Ltd. to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for Daewon Pharmaceutical Co. Ltd. (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Daewon Pharmaceutical Co. Ltd. from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Daewon Pharmaceutical Co. Ltd..
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 4.4% | ₩14.52 Billion | ₩327.53 Billion | ▲ +2.4 pp |
| 2018 | 2.1% | ₩5.69 Billion | ₩275.44 Billion | ▲ +0.8 pp |
| 2017 | 1.3% | ₩2.97 Billion | ₩227.20 Billion | ▲ +0.9 pp |
| 2016 | 0.5% | ₩973.06 Million | ₩214.68 Billion | ▲ +0.2 pp |
| 2015 | 0.2% | ₩462.30 Million | ₩194.75 Billion | ▼ 0.0 pp |
| 2014 | 0.2% | ₩437.85 Million | ₩180.62 Billion | ▼ -0.3 pp |
| 2013 | 0.6% | ₩932.36 Million | ₩160.14 Billion | — |